Trademark applications and grants for Altaire Pharmaceuticals Inc. Altaire Pharmaceuticals Inc has 17 trademark applications. The latest application filed is for "ALTAFLUOR"
Patent Application | Date |
---|---|
OPHTHALMIC COMPOSITIONS FOR REMOVING MEIBUM OR INHIBITING MEIBUM BUILDUP 20220031629 - 17/389680 Sawaya; Assad | 2022-02-03 |
OPHTHALMIC COMPOSITIONS FOR DELIVERING MEIBUM-LIKE MATERIALS 20220031625 - 17/389639 Sawaya; Assad | 2022-02-03 |
PRESERVATIVE-FREE FORMULATIONS OF TETRACAINE HCL 20210100769 - 16/657242 Sawaya; Assad | 2021-04-08 |
NCAGE Code | 032T4 | ALTAIRE PHARMACEUTICALS INC |
CAGE Code | 032T4 | ALTAIRE PHARMACEUTICALS INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.